DRUG

Bright Minds Biosciences Inc. NASDAQ Listed Mar 22, 2021

Healthcare ·Biotechnology ·CA · brightmindsbio.com

$89.08

Mkt Cap $691.4M

52w Low $23.18 65.5% of range 52w High $123.75

50d MA $80.73 200d MA $67.21

P/E (TTM) -48.9x

EV/EBITDA -35.9x

P/B 7.3x

Debt/Equity 0.0x

ROE —

P/FCF -66.8x

RSI (14) —

ATR (14) —

Beta -0.11

50d MA $80.73

200d MA $67.21

Avg Volume 145.0K

Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.

SIC Code

2834

CIK (SEC)

1827401

Phone

647 407 2515

1500 – 1055 West Georgia Street · New York City, BC V6E 4N7 · CA

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 12, 2026	AMC	-0.98	-0.70	+28.6%	80.57	+0.3%	-3.3%	+4.1%	-0.3%	+6.8%	+6.1%	—
Dec 23, 2025	AMC	-0.56	-0.41	+27.1%	84.27	+0.5%	+0.5%	-2.6%	-7.3%	-10.0%	-7.4%	—
Aug 14, 2025	AMC	-0.59	-0.53	+10.2%	42.54	+2.1%	-1.7%	+7.1%	+0.2%	+1.1%	-1.0%	—
Feb 13, 2025	AMC	-0.23	0.01	+104.3%	45.72	-1.7%	-8.6%	-18.0%	-18.2%	-20.9%	-21.3%	—
Dec 30, 2024	AMC	-0.44	-0.12	+72.9%	36.86	+2.3%	-2.3%	+11.5%	+8.1%	+12.3%	+9.1%	—
Aug 14, 2024	AMC	—	0.04	—	1.01	+4.0%	+2.0%	+5.9%	+1.0%	+0.0%	+2.0%	—
May 15, 2024	AMC	—	-0.10	—	1.09	+0.9%	-2.8%	+0.9%	+0.0%	+11.9%	+3.7%	—
Feb 12, 2024	AMC	—	-0.32	—	1.90	+4.2%	+1.6%	+3.2%	+3.2%	+2.6%	-1.6%	—
Dec 29, 2023	AMC	—	-0.30	—	1.43	+4.2%	+28.7%	+16.8%	+19.6%	+18.9%	+31.5%	—
Aug 14, 2023	AMC	—	-0.29	—	2.42	-2.5%	+9.5%	+6.6%	+6.2%	+8.7%	+7.9%	—
May 15, 2023	AMC	—	-0.08	—	2.70	+0.4%	+4.4%	+3.3%	-3.3%	-6.3%	-4.8%	—
Feb 7, 2023	AMC	—	-0.10	—	4.10	-1.7%	-4.9%	-11.0%	-8.5%	-9.5%	-9.0%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 30	BTIG	Maintains	Buy → Buy	—	$70.10	$70.89	+1.1%	-2.4%	+4.1%	+2.3%	+1.9%	+7.0%
Mar 4	HC Wainwright & Co.	Maintains	Buy → Buy	—	$80.00	$80.00	+0.0%	-0.9%	-2.8%	-3.9%	+0.6%	-0.5%
Feb 17	BTIG	Maintains	Buy → Buy	—	$77.90	$77.60	-0.4%	+7.7%	+3.1%	+10.5%	+9.7%	+11.0%
Jan 7	BTIG	Maintains	Buy → Buy	—	$93.21	$91.64	-1.7%	+3.0%	-3.4%	-6.9%	-4.9%	-4.1%
Jan 6	BTIG	Maintains	Buy → Buy	—	$80.01	$119.80	+49.7%	+16.5%	+20.0%	+12.5%	+8.4%	+10.8%
Jan 2	Chardan Capital	Maintains	Buy → Buy	—	$78.04	$79.51	+1.9%	+6.9%	+2.5%	+19.4%	+23.0%	+15.3%
Dec 30	HC Wainwright & Co.	Maintains	Buy → Buy	—	$78.12	$78.26	+0.2%	-2.9%	-0.1%	+6.8%	+2.4%	+19.3%
Sep 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$48.75	$48.80	+0.1%	-0.2%	-6.8%	-8.3%	+2.9%	+9.3%
Aug 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$45.55	$46.13	+1.3%	-6.4%	-5.6%	-7.5%	-3.5%	-8.5%
May 21	Chardan Capital	Maintains	Buy → Buy	—	$32.46	$32.10	-1.1%	-6.3%	-6.9%	-10.6%	-15.5%	-15.7%
Feb 19	HC Wainwright & Co.	Maintains	Buy → Buy	—	$37.51	$37.07	-1.2%	-0.3%	-3.6%	-4.1%	-4.2%	-9.3%

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
Apr 28, 2026	Cormorant Asset Management, LP	—	Sell	109,331	$89.50	$9.8M	950,000	-1.13%	+1.17%

Data updated apr 25, 2026 5:48am · Source: massive.com